$INCC Outlook - March 5. Although there has been

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
290
$INCC Outlook - March 5.

Although there has been absolutely no sign of the company selling shares since $INCC was last at .0001, it is evident that there is still some minor shorting going on - illogical small sells into the bid at non-retail prices even when there have been larger buys on the ask just prior - to give the illusion that there is continual selling in an attempt to dupe other small holders (with 5M>10M) to sell into a waiting bid (sometimes hidden with AON orders).

It may be that the intention of the bashers and their bosses is to get the price as low as possible before the next update.

The key to successful trading on $INCC in my experience is to build up a large inventory of shares at various price points (as you never know when the next run can be started by any one of 5 existing catalysts).

Personally, I buy a small amount (2M>5M) at every price increment on the way down. I'm now in the position that I never need to risk more than I have already banked on $INCC and can therefore deploy a multiple $5-figure sum on buying more at very low levels under .0005 to deny shares to bashers and low level flippers.

In the unlikely event that the price returns to the .0003/2/1 ask level, I will be buying much larger amounts of this low float stock on the ask when I feel the time is right. The buys will be large enough to set off scanners.

Studying the acquisition price / volume figures off the bottom last time - and taking into account other "intelligence" from studying posts and the trading patterns of other key shareholders - I doubt whether those that bought 176M at .0004 on the way up would sell for a 25% loss at .0003 with updates on 5 catalysts coming throughout the days, weeks and months ahead.

Shares will continue to be in short supply. Even when the A/S is doubled to 5B, the additional shares are going to be needed for acquisitions and will not be generally available to retail traders. Most of the stocks I've been trading concurrently since the start of 2017, and making huge profits on, have much higher A/Ss (up to 20B).

In my opinion, the returns on $INCC should continue to be higher due to the relatively thin share structure, fewer people trading it, and many of those trading it being very savvy traders who:

- Keep their lowest price shares the longest.

- Don't whack the bid.

- Don't stack the ask.

- Always have sufficient inventory to trade during big runs.

- Always have a significant lotto amount of "free" cost basis shares for mega runs to .01+.

- Have patience for catalysts / new developments to play out.

The 5 current catalysts upon which updates should continue are::

- Name change to Element 79, Inc.

- Ticker change.

- Closing already announced acquisition of non-public company SJR.

- Updates on ongoing negotiations for 2 other acquisitions in Uruguay and CA.

- Entry into sector of real estate holdings funding of clients mj businesses.

Tersis Technologies, Inc. (TERS) Stock Research Links

TERS Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Caldolor®: A Breakthrough in Opioid-Sparing Pain Relief for Seniors

Updated Category News Views 183

Revolutionizing Pain Management for Older Adults This comprehensive analysis reveals groundbreaking findings about Caldolor® (intravenous ibuprofen) and its effectiveness in managing pain for older adults. As the population ages, the need for safer alternatives for pain relief has significantly increased. Recent studies showcase a marked reduction in opioid consumption...

Continue Reading
Certara Stock Faces Challenges as it Hits a 52-Week Low

Updated Category News Views 120

Certara's Stock Market Performance Certara Inc. (NASDAQ: CERT), recognized as a frontrunner in biosimulation technology, has recently seen its stock price fall to a concerning 52-week low of $10.35. This price decline highlights a notable shift from its previous valuation, indicating a tumultuous time for shareholders. Over the last year, Certara's stock has experienced a...

Continue Reading
Urgent Reminder for WM Technology Shareholders on Lead Plaintiff Deadline

Updated Category News Views 159

Important Information for WM Technology Shareholders The Gross Law Firm is reaching out to shareholders of WM Technology, Inc. (NASDAQ: MAPS). This notice serves as a crucial reminder regarding the upcoming deadline for appointing a lead plaintiff in the class action lawsuit involving the company. Who Should Contact the Gross Law Firm? If you have purchased shares of MAPS...

Continue Reading
Nebraska Medicine Enhances Cancer Services with Expansion

Updated Category News Views 82

Nebraska Medicine Strengthens Cancer Care Network Nebraska Medicine is making significant strides in enhancing cancer care with the introduction of its new facility, Nebraska Medicine Fred & Pamela Buffett Cancer Center – Kearney. This expansion aims to serve communities across various regions, and it heralds an exciting phase for cancer treatment and research in the...

Continue Reading
Sunshine Silver's IPO: A Spotlight on Silver's Future

Updated Category News Views 8

Sunshine Silver Steps into the Spotlight Ah, the thrill of a fresh IPO. Sunshine Silver Mining & Refining Company, rolling under the ticker SSMR, has announced its initial public offering price—$13.50 a share, with 20 million shares up for grabs. This development has sure piqued the interest of traders eyeing some silver lining. The Figures That Matter Alright, let’s...

Continue Reading